Danske Bank’s Avanos Medical AVNS Stock Holding History

Danske Bank’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,040	Closed	-$40.6K	–	1614
2024 Q2	$40.6K	Hold	2,040	–	–	﹤0.01%	996
2024 Q1	$40.6K	Buy	+2,040	New	+$39.4K	﹤0.01%	1002

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Danske Bank's AVNS Position: Q3 2024 in Review

Danske Bank sold out of Avanos Medical (AVNS) in Q3 2024, closing a stake of 2,040 shares — an estimated $40.6K sold.

Danske Bank first reported a position in AVNS in Q1 2024 and held it in 2 quarters. The position peaked at $40.6K in Q2 2024. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2024.

Danske Bank reported no remaining Avanos Medical position as of Q3 2024 after selling out during the quarter.
Danske Bank sold 2,040 Avanos Medical shares in Q3 2024, an estimated $40.6K.
Danske Bank first reported a position in Avanos Medical in Q1 2024 and held it in 2 quarters.
Danske Bank's Avanos Medical position peaked at $40.6K in Q2 2024.
260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2024.

Based on Danske Bank's 13F filing for Q3 2024, filed 18 Mar 2026.